Here, we have investigated the mechanism through which TKIs lead to G1 arrest in vitro in primary CD34+ CML cells and in vivo in the SCLtTA/BCR-ABL mouse model of CML 27. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.